Tower Research Capital LLC (TRC) - ONCONOVA THERAPEUTICS INC ownership

ONCONOVA THERAPEUTICS INC's ticker is ONTX and the CUSIP is 68232V801. A total of 27 filers reported holding ONCONOVA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ONCONOVA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,568
-55.5%
3,508
+0.6%
0.00%
Q1 2024$3,522
+33.0%
3,487
-1.7%
0.00%
Q4 2023$2,648
-1.5%
3,549
-6.2%
0.00%
Q3 2023$2,689
-35.8%
3,782
+6.6%
0.00%
Q2 2023$4,186
+104550.0%
3,548
-32.4%
0.00%
Q1 2023$4
-99.9%
5,245
+254.6%
0.00%
Q1 2022$3,000
-62.5%
1,479
-52.2%
0.00%
Q4 2021$8,000
-63.6%
3,096
-47.2%
0.00%
-100.0%
Q3 2021$22,0005,859
+13850.0%
0.00%
Q2 2021$0420.00%
Other shareholders
ONCONOVA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Hillcrest Wealth Advisors - NY, LLC 16,723$22,0000.01%
EMFO, LLC 3,333$4,0000.00%
TWO SIGMA ADVISERS, LP 178,912$236,0000.00%
Beacon Pointe Advisors, LLC 51,976$68,0000.00%
Renaissance Technologies 333,323$440,0000.00%
BANK OF AMERICA CORP /DE/ 33$00.00%
Cordasco Financial Network 132$00.00%
JANE STREET GROUP, LLC 14,977$20,0000.00%
WELLS FARGO & COMPANY/MN 131$00.00%
NORTHERN TRUST CORP 30,783$41,0000.00%
View complete list of ONCONOVA THERAPEUTICS INC shareholders